Evidence map›Paper›PMID 9284154›Full record

ArticleInfection and immunity1997

Heterogeneity of antibodies reactive with the dominant antigen of Actinobacillus actinomycetemcomitans.

K Nakashima, H A Schenkein, J V Califano, J G Tew

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

K NakashimaClinical Research Center for Periodontal Diseases, School of Dentistry, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298, USA.
H A Schenkein
J V Califano
J G Tew
Virginia Commonwealth University Medical Center · US

Funding

RESEARCH CENTER FOR PERIODONTAL DISEASESP50DE010703 · NIDCR · VIRGINIA COMMONWEALTH UNIVERSITY · PI SCHENKEIN, HARVEY ALLEN · 1993 to 1998
–
PROTECTIVE ANTIBODY RESPONSES IN JUVENILE PERIODONTITISR29DE010371 · NIDCR · VIRGINIA COMMONWEALTH UNIVERSITY · PI CALIFANO, JOSEPH V. · 1992 to 1996
–
NIDCR NIH HHS DE10371NIDCR NIH HHS DE10703
6 · The paper itself

Abstract

The serotype b-specific carbohydrate antigen (SbAg) of Actinobacillus actinomycetemcomitans Y4 is reported to be the O antigen of lipopolysaccharide, and the highest titers of serum antibody reactive with A. actinomycetemcomitans in early-onset periodontitis (EOP) patients bind SbAg. These high titers of serum antibody reactive with SbAg are associated with a lesser extent and severity of periodontal disease. The aim of this study was to determine if a limited number of genes code for anti-SbAg antibodies as has been shown for immunoglobulin G (IgG) reactive with the type b polysaccharide from Haemophilus influenzae. Serum IgG reactive with the SbAg was prepared from 20 high-titer EOP patients by affinity chromatography. The IgG subclass concentrations were determined, and heterogeneity was analyzed by isoelectric focusing (IEF). IgG2 was the dominant subclass (83% of total IgG) in the anti-SbAg IgG fraction and represented an average of 1.33% of total serum IgG2. The IgG2 reactive with SbAg was isolated from the affinity-purified IgG fraction by affinity chromatography with protein A and subclass-specific monoclonal antibodies. On IEF gels, only 4 to 20 bands were observed in the anti-SbAg IgG fractions, indicating limited heterogeneity. N-terminal amino acid sequence analysis of eight representative anti-SbAg IgG2 preparations indicated that variable heavy and light chains consisted largely of V(H)III and V(kappa)II, respectively. However, a significant fraction of anti-SbAg may use V(H) and V(lambda) genes with blocked N termini. In short, these findings indicate that IgG reactive with SbAg is very much like the antibody reactive with H. influenzae type b polysaccharide. Similarities include IgG2 dominance, limited bands on IEF gels, supporting an oligoclonal response, and use of genes from V(H)III and V(kappa)II regions.

Indexed as

Aggregatibacter actinomycetemcomitansAmino Acid SequenceAntibodies, BacterialAntibody AffinityAntibody DiversityHumansImmunoglobulin GImmunoglobulin IsotypesImmunoglobulin kappa-ChainsImmunoglobulin lambda-ChainsIsoelectric PointMolecular Sequence DataAntibodies, BacterialImmunoglobulin GImmunoglobulin IsotypesImmunoglobulin kappa-ChainsImmunoglobulin lambda-Chains

Identifiers

PMID9284154
PMCPMC175541
OpenAlexW1933618965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.